Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc > does anyone see this stock hitting $8.00 in the future?

<< Previous

Bullboard Posts

Next >>

Comment by 666999on Feb 06, 2021 8:58am

123 Views

Post# 32492371

RE:does anyone see this stock hitting $8.00 in the future?

Why not its possible, I say 200 M mkt cap is easy acchiavable and around corner, but for future share price who knows 2,3,4,5 CAD maybe some day
Im in at 0.25 and will hold shares as things are progressing well
Glta

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks